Cervical cancer originates in the cells of the cervix, the lower cylindrical portion of the uterus that opens into the vagina. It develops primarily in the transformation zone where the squamous epithelium of the ectocervix meets the columnar epithelium of the endocervix. Globally and within Nigeria, it remains a major public health concern, disproportionately affecting women in low-resource settings due to limited access to routine screening services.
Persistent infection with high-risk types of the Human Papillomavirus (HPV), particularly types 16 and 18, is the primary etiological agent responsible for nearly all cervical malignancies. Unlike many other adult cancers, viral persistence drives the disease process. Several co-factors elevate risk by facilitating viral persistence or promoting cellular dysplasia:
Infection begins when HPV enters micro-abrasions in the cervical epithelium, infecting basal cells. High-risk viral proteins, specifically E6 and E7, inactive host tumor suppressor proteins p53 and retinoblastoma (Rb). This inactivation leads to uncontrolled cellular division and genomic instability.
Over time, persistent infection progresses through distinct histological stages known as cervical intraepithelial neoplasia (CIN):
Early-stage cervical cancer is frequently asymptomatic, which underscores the necessity of screening programs. As the tumor grows and invades deeper stroma or vascular channels, clinical signs emerge. The hallmark symptom is abnormal vaginal bleeding, including post-coital bleeding, intermenstrual bleeding, and foul-smelling watery or blood-tinged vaginal discharge. Advanced disease causes pelvic pain, lower back ache, leg swelling from lymphatic obstruction, and urinary symptoms if the bladder is involved.
Staging relies heavily on the FIGO (International Federation of Gynecology and Obstetrics) system, transitioning from localized cervical involvement to distant metastasis.
Community health nurses play a pivotal role in reducing cervical cancer morbidity through primary screening initiatives.
| Screening Method | Description | Clinical Utility |
|---|---|---|
| Pap Smear (Cytology) | Scrapes cells from the transformation zone for microscopic review | Detects cellular dysplasia before malignancy develops |
| HPV DNA Testing | Detects genetic material of high-risk viral strains | High sensitivity for persistent high-risk infections |
| Visual Inspection with Acetic Acid (VIA) | Applies 3-5% vinegar solution to reveal acetowhite lesions | Rapid, low-cost option suitable for low-resource primary care clinics |
When screening results return abnormal, definitive diagnostic workup is required. A colposcopy magnifies the cervical epithelium using a specialized binocular microscope, allowing visualization of vascular patterns and iodine uptake abnormalities. During colposcopy, directed punch biopsies are taken from suspicious areas. If endocervical involvement is suspected or the transformation zone is not fully visible, an endocervical curettage (ECC) is performed. Histological confirmation through biopsy remains the gold standard for diagnosing cervical cancer.
Treatment modalities depend heavily on the clinical stage of the tumor, patient age, and overall health status.
Comprehensive nursing care addresses the complex physical and emotional needs of patients undergoing treatment and those with advanced disease. Nurses manage acute treatment side effects, such as radiation-induced cystitis, proctitis, and bone marrow suppression. For patients with advanced or terminal cervical cancer, palliative care focuses on pain management using the WHO analgesic ladder, controlling malodorous vaginal discharge, and offering psychological support to the patient and their family.
Primary prevention focuses on stopping HPV infection before it occurs. Prophylactic vaccines target major oncogenic types and are most effective when administered to adolescents before sexual debut. Community health campaigns must also dispel cultural misconceptions about vaccines and promote barrier contraceptives. While condoms reduce transmission risk, they do not provide absolute protection because HPV can infect skin areas not covered by barrier methods.